| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/14/2009 | CN101342300A Traditional Chinese medicine capsule for treating atrioventricular block |
| 01/14/2009 | CN101342274A Curculigo orchioides extract, preparation method and uses thereof |
| 01/14/2009 | CN101342259A Method for extracting alkaloid valid target from hooked uncaria leaf, with hook stem branch or full grass and uses thereof |
| 01/14/2009 | CN101342256A Medicament for treating hyperpiesis, cardiac disease and preparation method thereof |
| 01/14/2009 | CN101342254A Combination of traditional Chinese medicine extract for preventing and treating atherosis, hyperlipemia, and preparation thereof |
| 01/14/2009 | CN101342238A Medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 01/14/2009 | CN101342237A Traditional Chinese medicine extract combination for preventing and treating atherosis and preparation thereof |
| 01/14/2009 | CN101342236A Method for preparing red sage root extract, red sage root extract and medicament composition containing the same |
| 01/14/2009 | CN101342230A Radix astragali particle and quality control method thereof |
| 01/14/2009 | CN101342208A Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia and preparation method thereof |
| 01/14/2009 | CN101342207A Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia, hyperlipemia and preparation method thereof |
| 01/14/2009 | CN101342161A Application of frangula emodin, aloe-emodin in preparing anti-cerebral ischemia damnification medicament |
| 01/14/2009 | CN101342160A Application of ocean bromine phenol in preparing medicament for treating antithrombotic forming function |
| 01/14/2009 | CN101342151A Isosorbide mononitrate osmotic pump type controlled release formulation and preparation method thereof |
| 01/14/2009 | CN101342150A Method for preparing isosorbide mononitrate orally disintegrating tablets |
| 01/14/2009 | CN101342149A Process for preparing granisetron hydrochloride orally disintegrating tablets |
| 01/14/2009 | CN101341979A Health beverage and preparation method |
| 01/14/2009 | CN100451127C Peptides with anti-hypertensive properties |
| 01/14/2009 | CN100451005C Deoxyneohydroxyaspergillic acid and its prepn and use |
| 01/14/2009 | CN100451004C Novel quinoline,Tetrahydroquinazoline,And pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/14/2009 | CN100450539C Use of medicinal composition containing pilose antler for treating chronic brain blood supply deficiency |
| 01/14/2009 | CN100450501C Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 01/14/2009 | CN100450497C Plant seed extract composition and process for producing the same |
| 01/14/2009 | CN100450496C Compound preparation of notoginseng and safflower for treating cardiovascular and cerebrovascular diseases |
| 01/14/2009 | CN100450495C Method for processing ginseng and the uses of extract of processed ginseng |
| 01/14/2009 | CN100450494C Medicinal use of Aralia continentalis kitag |
| 01/14/2009 | CN100450489C Huangyangning drop pills and preparation method |
| 01/14/2009 | CN100450483C Stabilized pharmaceutical compositions contg. calcium channel blockers |
| 01/14/2009 | CN100450478C Pharmaceutical composition |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/14/2009 | CN100450476C Electrolyte complementary medical combination for injection |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476743 Treating cellular proliferation disease with 1,2,5-triazol-5-one and as an anticancer agent and inhibitor of kinesins for treatment of hyperplasia or restenosis |
| 01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476662 Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2385402C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 01/13/2009 | CA2337397C 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/13/2009 | CA2237273C Angiogenesis inhibiting pyridazinamines |
| 01/08/2009 | WO2009006089A2 A2 adenosine receptor agonists |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009005877A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | WO2009005646A2 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | WO2009005645A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | WO2009005464A1 New use of known pharmacologically active chemical compounds |
| 01/08/2009 | WO2009005386A1 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009005002A1 Quinolone derivative |
| 01/08/2009 | WO2009004999A1 Seamless capsule |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004990A1 Fp receptor agonist |
| 01/08/2009 | WO2009004650A1 Novel substituted piperidones as hsp inducers |
| 01/08/2009 | WO2009004064A1 Process for preparing telmisartan |
| 01/08/2009 | WO2009003861A1 Imidazole derivatives as ccr2 receptor antagonists |
| 01/08/2009 | WO2009003831A1 Food composition comprising p-coumaric acid and its use to control blood pressure |
| 01/08/2009 | WO2009003798A1 Food composition comprising trans-resveratrol and its use to control blood pressure |
| 01/08/2009 | WO2009003356A1 A pharmaceutical composition for decreasing the area of myocardial infarct and application thereof |
| 01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | US20090012413 Cardiac patterning for improving diastolic function |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012183 Composition comprising polyphenol |
| 01/08/2009 | US20090012168 Adiponection inducers or secretagogues |
| 01/08/2009 | US20090012156 Composition comprising polyphenol |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012148 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| 01/08/2009 | US20090012140 Preparation of Telmisartan Salts with Improved Solubility |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012115 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations |
| 01/08/2009 | US20090012114 Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same |
| 01/08/2009 | US20090012112 Alpha 1A-adrenoceptor antagonists |
| 01/08/2009 | US20090012103 Substituted heterocyclic compounds |
| 01/08/2009 | US20090012096 Pharmaceutical composition for reducing the area of myocardial infarction and its use |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012063 Novel imidazole derivatives |
| 01/08/2009 | US20090012057 Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use |
| 01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
| 01/08/2009 | US20090012040 Biocompatible polymers, process for their preparation and compositions containing them |
| 01/08/2009 | US20090012036 Stable S-adenosyl-L-methionine |
| 01/08/2009 | US20090012027 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/08/2009 | US20090012020 Inhibiting formation of atherosclerotic lesions |
| 01/08/2009 | US20090012005 Use of an angiotensin IV antagonist to treat insulin resistance or cardiovascular risk related to metabolic syndrome |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 01/08/2009 | US20090011987 Use of Glp-2 for the Treatment of Ischemia-Reperfusion Injury |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011055 Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090010993 Composition comprising polyphenol |
| 01/08/2009 | US20090010987 Methods and Devices for Reducing Tissue Damage After Ischemic Injury |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010978 Green tea jewelry |